116 related articles for article (PubMed ID: 19040105)
21. Synthesis of some novel heterocylic compounds derived from 2-[3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol-4-yl]acetohydrazide and investigation of their lipase and α-glucosidase inhibition.
Bekircan O; Ülker S; Menteşe E
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1002-9. PubMed ID: 25640970
[TBL] [Abstract][Full Text] [Related]
22. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis.
Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E
Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.
Bayrak H; Demirbas A; Demirbas N; Karaoglu SA
Eur J Med Chem; 2009 Nov; 44(11):4362-6. PubMed ID: 19647352
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives.
Al-Soud YA; Al-Dweri MN; Al-Masoudi NA
Farmaco; 2004 Oct; 59(10):775-83. PubMed ID: 15474054
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
27. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds.
Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.
Lv Z; Sheng C; Wang T; Zhang Y; Liu J; Feng J; Sun H; Zhong H; Niu C; Li K
J Med Chem; 2010 Jan; 53(2):660-8. PubMed ID: 20000776
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and antibacterial activity of 3-(5-substituted phenyl-[1,3,4] oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl-[1,2,4] triazole-4-yl-amines].
Hu GQ; Xie SQ; Xu QJ; Huang WL; Zhang HB; Huang ST
Yao Xue Xue Bao; 2005 Apr; 40(4):337-9. PubMed ID: 16011262
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities.
Bayrak H; Demirbas A; Karaoglu SA; Demirbas N
Eur J Med Chem; 2009 Mar; 44(3):1057-66. PubMed ID: 18676062
[TBL] [Abstract][Full Text] [Related]
33. The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species.
Çavuşoğlu BK; Yurttaş L; Cantürk Z
Eur J Med Chem; 2018 Jan; 144():255-261. PubMed ID: 29274492
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
[TBL] [Abstract][Full Text] [Related]
35. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
36. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors.
Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X
Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
Lin M; Yang LY; Li WY; Peng YP; Zheng JK
J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
[TBL] [Abstract][Full Text] [Related]
39. Anti-HAV activity of some newly synthesized triazolo[4,3-b]pyridazines.
Shamroukh AH; Ali MA
Arch Pharm (Weinheim); 2008 Apr; 341(4):223-30. PubMed ID: 18214848
[TBL] [Abstract][Full Text] [Related]
40. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.
Moshier JA; Mutchnick MG; Dosescu J; Holtz TK; Akkary S; Mahakala K; Merline JR; Naylor PH
J Hepatol; 1996 Dec; 25(6):814-20. PubMed ID: 9007707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]